Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05563103 · ClinicalTrials.gov registry record · NA

Combination Therapy to Improve SCI Recovery.

A NA study of Spinal Cord Injuries, sponsored by Spaulding Rehabilitation Hospital.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
2
Study locations

NCT05563103 is a NA study of Spinal Cord Injuries that is actively recruiting participants, run by Spaulding Rehabilitation Hospital. The registered enrollment target is 60 participants, roughly in line with the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target. The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05563103, a NA study of Spinal Cord Injuries, is actively recruiting participants, sponsored by Spaulding Rehabilitation Hospital.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to determine how combining bouts of low oxygen, transcutaneous spinal cord stimulation, and walking training may improve walking function for people with chronic spinal cord injury.

Conditions Studied

Interventions

  • OTHER Daily acute intermittent hypoxia
  • OTHER Room air (SHAM)
  • OTHER Walking + tSTIM
  • OTHER Walking + Sham transcutaneous spinal stimulation (tSHAM)

Study Locations (2)

Illinois

  • Shirley Ryan AbilityLab - Chicago

Massachusetts

  • Spaulding Rehabilitation Hospital - Cambridge

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2023-01-17
Est. Completion 2026-12
Phase NA

Sponsor

Spaulding Rehabilitation Hospital

101 total trials

What the Registry Record Tells You About NCT05563103

The ClinicalTrials.gov registry entry for NCT05563103 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target. The listed sponsor is Spaulding Rehabilitation Hospital, which has 101 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Spinal Cord Injuries appearing as the primary indexed condition, and to 4 interventions - of which Daily acute intermittent hypoxia is the first listed.

NCT05563103 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Illinois, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05563103 about?

NCT05563103 is a clinical study titled "Combination Therapy to Improve SCI Recovery.". The purpose of this study is to determine how combining bouts of low oxygen, transcutaneous spinal cord stimulation, and walking training may improve walking function for people with chronic spinal cord injury.

What is the current status of trial NCT05563103?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2023-01-17. Estimated completion is 2026-12.

What conditions does trial NCT05563103 study?

This clinical trial studies the following conditions: Spinal Cord Injuries.

What interventions are being tested in trial NCT05563103?

The interventions under investigation include: Daily acute intermittent hypoxia (OTHER), Room air (SHAM) (OTHER), Walking + tSTIM (OTHER), Walking + Sham transcutaneous spinal stimulation (tSHAM) (OTHER).

Who is sponsoring clinical trial NCT05563103?

This trial is sponsored by Spaulding Rehabilitation Hospital, which has 101 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05563103 being conducted?

This trial has 2 study locations across Illinois, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.